Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Prepaid Assets (2016 - 2026)

Intellia Therapeutics has reported Prepaid Assets over the past 12 years, most recently at $81.3 million for Q1 2026.

  • Quarterly Prepaid Assets rose 118.98% to $81.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $81.3 million through Mar 2026, up 118.98% year-over-year, with the annual reading at $68.4 million for FY2025, 129.15% up from the prior year.
  • Prepaid Assets was $81.3 million for Q1 2026 at Intellia Therapeutics, up from $68.4 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $81.3 million in Q1 2026 and troughed at $18.3 million in Q2 2022.
  • The 5-year median for Prepaid Assets is $36.8 million (2025), against an average of $40.3 million.
  • Year-over-year, Prepaid Assets surged 143.3% in 2023 and then crashed 39.92% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $20.4 million in 2022, then skyrocketed by 143.3% to $49.7 million in 2023, then crashed by 39.92% to $29.8 million in 2024, then surged by 129.15% to $68.4 million in 2025, then rose by 18.98% to $81.3 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Prepaid Assets are $81.3 million (Q1 2026), $68.4 million (Q4 2025), and $59.8 million (Q3 2025).